||EPS - Basic
||Market Cap (m)
Byotrol Share Discussion Threads
Showing 6426 to 6446 of 6450 messages
|By all means cross your fingers, but don't hold your breath.|
|So Byotrol is losing around £1million per year on a trading basis but believe that milestone and partnership payments, together with R&D tax credits, should add in excess of GBP1.1m to revenues and gross margin in H2,thus enabling an EBITDA positive position to be achieved.
No wonder the share price failed to make any further progress.
Fingers crossed for something more constructive in 2017.|
|I have a very balanced portfolio. Not really sure what you are on about|
|brownson, glad to see you have a balanced portfolio and not invested in just one share.
Hey, there's a guy on the LSE just like you..|
|Frankly, I couldn't do a lot worse. The interims speak for themselves. Worse than last year. Time it was closed down|
|brownson-er- and a happy Christmas to you too ! Not a very kind message.....i wonder if you would run it any better ....i doubt it.|
|Looking like Mudbath made a wise decision|
|If Byotrol is left as the one that can prove efficacy, it could be very positive. If not its a big downer|
|FDA: " Antibacterial soap? You can skip it --- Use plain soap and water." 2/9/2016|
|Is that the end of the little flurry of activity? I presume we are stuck at this level for the next year or two while profitability gets ever closer , though never quite happens|
|the way i see it if any one large co adopts this then every big cleanser company will have to license it as the big marketing spend of anyone of them will make hay with the Byotrol advantages. The ARM model comes to mind. Tiny fees x massive volume markets.|
|I told you Mud had called the bottom - classic!!
This was always going to be a licensed tech - the cleaning materials industry is just far too monopolistic to allow a minnow manufacturer in|
|It was waiting for you to bog off mud.|
|cant see where anyone has posted the last RNS so here is
Byotrol plc, the specialist anti-microbial technology company, is pleased to announce its final results for the 12 months ended 31 March 2016.
We last updated the market in early July; we are pleased to confirm that our final, audited results are in line with that update. Highlights of the year include:
EBITDA loss before exceptionals of £449k versus £526k in the previous year
Sharply narrowed loss after tax of £532k (after all exceptionals and tax credits) versus a loss of £749k the previous year
Cash and cash equivalents of over £1mn, compared to £287k in the prior year
Continued moves to higher margin transactions, especially by way of licensing and development deals, including with KYORIN Pharmaceutical Co., Ltd (hand sanitisers in Japan), Rentokil Initial plc (hand sanitisers in UK washrooms) and Beaphar NA (surface care products for pet environments) in continental Europe
Further and expanded agreement to develop and commercialise long-lasting biocidal products for hard surfaces with Solvay Novecare, a world leader in specialty polymers and surfactants and a global business unit of the international chemical group Solvay SA (“Solvay").
We also confirm continued progress in the technical tests required for formal Environmental Protection Agency (EPA) approval of our surface sanitising products in the US, with an expected registration filing date in early December 2016.
Annual Report & Accounts for the year ended 31 March 2016 have today been posted to shareholders together with the Notice of Annual General Meeting, which will be held at 10am on 22 September 2016 at the offices of finnCap at 60 Broad Street, London EC2M 1JJ.
An electronic copy of the Annual Report and Accounts is also available from the Company’s website: www.byotrol.co.uk.
Trading for the current year to 31 March 2017 is proceeding to plan, with continued emphasis on higher margin contracts and customers.
As previously notified to shareholders, under the terms of the agreement with Solvay, Solvay will be making substantial payments to the Company. All of those payments are fully committed and will be made in the second half of the current financial year.
David Traynor, Chief Executive of Byotrol plc comments:
“We are now showing progress in turning our low-margin, product sales business into a higher margin technology company. We are very confident about our future.”|
|I've now tried my 3 nearest Boots and you can't get the Byotrol hand cleanser in any of them. BYT says they're getting revenue from the new product, but it isn't listed on their website and certainly isn't in stores.
There's still a gap between ambition and execution.|
|Tosco are knocking out the Byotrol cleaner at £0.70 now
or you can have the cheepo anti bac generic version @ £0.50:
And Dettol (anti bac) was marked at a quid a go (in store)
Sounds like a race to the bottom on the cleaner stakes.|
|Mudbath out!That is definitely calling the bottom on this. Buffet said investing transfers wealth from the impatient to the patient. . .|
|The oldest and the most wizened maybe emeraldbra.|
|Mud that is astonishing and not a little sad perhaps. Had you down as the oldest and the wisest. Get back in quick ! lol|
|Not everyone is as impressed though.
From the pen of IdeasByScience:-
"That’s an enviable list of customers / prospects that have not delivered – the comment attached to Rentokil perhaps explains perfectly why Byotrol is where it is: seeing day and saying it is night. To use a metaphor, the emperor’s new clothes fit but are very run of the mill style wise.
Keep on passing the tests, but we are out at 4p, bitterly disappointed with an in at 13p."
It may come right for BYOT but I too am now out.|
|Hi Muddo (yes, long time no see), firth and all Byoteers. Results look ok to me (a meaningless statement)and technicals are starting to look promising (I've said that before and regretted it).
But could this be the turning point? The Jim Crowley effect? I live in hope.|